Jordan · Delayed Price · Currency is JOD Ligand Pharmaceuticals Statistics
Total Valuation
ASE:INMA has a market cap or net worth of JOD 750,000. The enterprise value is 1.39 million.
| Market Cap | 750,000 |
| Enterprise Value | 1.39M |
Important Dates
The last earnings date was Wednesday, July 30, 2025.
| Earnings Date | Jul 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ASE:INMA has 3.00 million shares outstanding.
| Current Share Class | 3.00M |
| Shares Outstanding | 3.00M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 19.82% |
| Owned by Institutions (%) | 4.29% |
| Float | 1.54M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 11.09 |
| PB Ratio | 0.27 |
| P/TBV Ratio | 0.27 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 1.68 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -6.41 |
| EV / Sales | 20.61 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.57, with a Debt / Equity ratio of 0.23.
| Current Ratio | 1.57 |
| Quick Ratio | 1.34 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.28 |
Financial Efficiency
Return on equity (ROE) is -7.48% and return on invested capital (ROIC) is -1.54%.
| Return on Equity (ROE) | -7.48% |
| Return on Assets (ROA) | -0.95% |
| Return on Invested Capital (ROIC) | -1.54% |
| Return on Capital Employed (ROCE) | -3.00% |
| Revenue Per Employee | 16,912 |
| Profits Per Employee | -54,359 |
| Employee Count | 4 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -31.43% in the last 52 weeks. The beta is 0.29, so ASE:INMA's price volatility has been lower than the market average.
| Beta (5Y) | 0.29 |
| 52-Week Price Change | -31.43% |
| 50-Day Moving Average | 0.26 |
| 200-Day Moving Average | 0.31 |
| Relative Strength Index (RSI) | 46.04 |
| Average Volume (20 Days) | 12,807 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASE:INMA had revenue of JOD 67,647 and -217,437 in losses. Loss per share was -0.07.
| Revenue | 67,647 |
| Gross Profit | 30,600 |
| Operating Income | -90,943 |
| Pretax Income | -217,437 |
| Net Income | -217,437 |
| EBITDA | -68,813 |
| EBIT | -90,943 |
| Loss Per Share | -0.07 |
Balance Sheet
The company has 813 in cash and 645,105 in debt, giving a net cash position of -644,292 or -0.21 per share.
| Cash & Cash Equivalents | 813 |
| Total Debt | 645,105 |
| Net Cash | -644,292 |
| Net Cash Per Share | -0.21 |
| Equity (Book Value) | 2.80M |
| Book Value Per Share | 0.93 |
| Working Capital | 1.54M |
Cash Flow
| Operating Cash Flow | 447,202 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 45.23% |
| Operating Margin | -134.44% |
| Pretax Margin | -321.43% |
| Profit Margin | n/a |
| EBITDA Margin | -101.72% |
| EBIT Margin | -134.44% |
| FCF Margin | n/a |
Dividends & Yields
ASE:INMA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -28.99% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 5, 2021. It was a reverse split with a ratio of 0.4285720408.
| Last Split Date | Sep 5, 2021 |
| Split Type | Reverse |
| Split Ratio | 0.4285720408 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |